#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Haemolytic uraemic syndrome Haemophilia A with anti factor VIII Rheumatoid arthritis Sexually transmitted disease Acquired ATTR amyloidosis Prolymphocytic leukaemia Medulloblastoma Hyperoxaluria Epidermolysis bullosa Bronchiectasis Postprandial hypoglycaemia Chronic graft versus host disease in intestine Liposarcoma Allogenic stem cell transplantation Alexander disease More trials…

    Learn about Rare Diseases

    Systemic mastocytosis – Diagnostics Mantle cell lymphoma stage II – Basic Information Langerhans’ cell histiocytosis – Life with Disease Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome – Diagnostics Ewing’s sarcoma recurrent Congenital hypotransferrinaemia – Life with Disease Usher’s syndrome – Trials in Disease Bronchopulmonary dysplasia – Diagnostics Antithrombin III deficiency – Basic Information Indolent systemic mastocytosis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Clemastine Fumarate IHMA-2121771-2 Bi 3032950 Ticagrelor Misoprostol Iph5201 Salbutamol Sulfate Ph. Eur. Satoreotide Tetraxetan Thiotepa Pegfilgrastim RIKKUNSHITO VORMATRIGINE Etanercept Phentermine IMELASOMERAN ANXV ULTEVURSEN Mesalazine Dazucorilant Rbp030.2 More therapies…

    Learn about Your Condition

    Malignant neoplasm of choroid Tooth loss Herpes simplex Immunodeficiency congenital Osteoporosis postmenopausal Neuropathy peripheral Angiosarcoma Ovarian cancer stage III Arteriovenous graft thrombosis Diabetic foot infection Colorectal cancer stage III Diabetic ketoacidosis Critical illness Genital herpes simplex Perthes disease More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Cardiac failure chronic

  • Study on the Effects of Dapagliflozin for Patients with Refractory Heart Failure

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Dapagliflozin
    Spain

  • A feasibility study of dapagliflozin for elderly patients hospitalized with chronic heart failure.

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    • Cardiac failure
    Investigated Drugs:
    • Dapagliflozin Propanediol Monohydrate
    France

  • Study of cardiac atrial stem cells injected into heart muscle for treating advanced heart failure in patients with prior heart attack and reduced heart function

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure congestive
    • Chronic left ventricular failure
    • Left ventricular failure
    Belgium

  • Study on the Effects of Colchicine on Blood Vessel Function in Patients with Chronic Heart Failure and CHIP Mutations

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Colchicine
    Germany

  • Study on Hydralazine, Isosorbide Dinitrate, and Metformin for Patients with Chronic Heart Failure and Reduced Heart Function

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Hydralazine Hydrochloride
    • Isosorbide Dinitrate
    • Metformin Hydrochloride
    Denmark

  • Study on the Effects of Digoxin and Activated Charcoal in Treating Heart Failure in Patients Receiving Standard Care

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure chronic
    Investigated Drugs:
    • Charcoal, Activated
    • Digoxin Immune Fab (Ovine)
    • Digoxin
    Portugal
Previous Page
1 2 3
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!